Vivani Medical- Warrants (14/03/2024) Return on Equity

The latest ROE for VANIW is -138.73%. That is below the Healthcare sector average of 13.26%. Investors often review this figure alongside Vivani Medical- Warrants (14/03/2024)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, VANIW currently prints -138.73% for ROE, while the sector average sits near 13.26%. That is roughly 1146.0% below the sector mean. Large gaps often invite a closer look at Vivani Medical- Warrants (14/03/2024)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Vivani Medical- Warrants (14/03/2024) converts resources into returns. At -138.73%, VANIW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting VANIW's ROE (-138.73%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Vivani Medical- Warrants (14/03/2024)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.